1621681-63-7 (1-N-[4-(6,7-二甲氧基-1-氧化喹啉-1-基-4-基)氧基苯基]-1-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺,Cabozantinib N-oxide)

LKX6L2LD4X;BDBM381929;US10273211, Compound 19;1-N-[4-(6,7-Dimethoxy-1-oxidoquinolin-1-ium-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-di;Cabozantinib N-oxide;4-(4-(1-((4-Fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide;1621681-63-7;SCHEMBL16083437;N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;G66625;Cabozantinib metabolite M19;1,1-Cyclopropanedicarboxamide, N-(4-((6,7-dimethoxy-1-oxido-4-quinolinyl)oxy)phenyl)-N'-(4-fluorophenyl)-;1-N-[4-(6,7-dimethoxy-1-oxidoquinolin-1-ium-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;UNII-LKX6L2LD4X;N-(4-((6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy)phenyl)-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;EXEL-5162;

FKJJTKYQXXLFPS-UHFFFAOYSA-N

1S/C28H24FN3O6/c1-36-24-15-21-22(16-25(24)37-2)32(35)14-11-23(21)38-20-9-7-19(8-10-20)31-27(34)28(12-13-28)26(33)30-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,30,33)(H,31,34)

FC1C([H])=C([H])C(=C([H])C=1[H])N([H])C(C1(C(N([H])C2C([H])=C([H])C(=C([H])C=2[H])OC2C([H])=C([H])[N+](=C3C([H])=C(C(=C([H])C=23)OC([H])([H])[H])OC([H])([H])[H])[O-])=O)C([H])([H])C1([H])[H])=O